Article
Version 1
Preserved in Portico This version is not peer-reviewed
Universal mRNA-based HIV Vaccine for Acute and Latent Infections
Version 1
: Received: 15 March 2024 / Approved: 18 March 2024 / Online: 18 March 2024 (11:24:43 CET)
How to cite: Niazi, S. K.; Magoola, M. Universal mRNA-based HIV Vaccine for Acute and Latent Infections. Preprints 2024, 2024031035. https://doi.org/10.20944/preprints202403.1035.v1 Niazi, S. K.; Magoola, M. Universal mRNA-based HIV Vaccine for Acute and Latent Infections. Preprints 2024, 2024031035. https://doi.org/10.20944/preprints202403.1035.v1
Abstract
Human Immunodeficiency Virus (HIV) infection and its latent recurrent infection make vaccine development a significant challenge for traditional vaccines; however, the mRNA delivery of multiepitope antigens capable of creating antibodies against the surface proteins of HIV-1 and HIV-2 along with their respective Nef proteins, responsible for the latent infection can bring a most effective, as well as affordable solution to the unresolved epidemics of HIV. In this paper, we present the complete design of a multiepitope vaccine to prevent acute infections and inactivate Nef proteins that block the MHC-1 and MHC-2 pathways to hide the virus for later reinfection.
Keywords
HIV-1 1; HIV-2 2; surface proteins 3; Nef proteins 4; mRNA delivery 5; Universal vaccine.
Subject
Medicine and Pharmacology, Immunology and Allergy
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment